Affordable Access

Postsclerotherapy hyperpigmentations. Chromated glycerin as a screen for patients at risk (a retrospective study).

Authors
Type
Published Article
Journal
The Journal of Dermatologic Surgery and Oncology
0148-0812
Publisher
Wiley Blackwell (Blackwell Publishing)
Publication Date
Volume
19
Issue
7
Pages
649–652
Identifiers
PMID: 8349903
Source
Medline
License
Unknown

Abstract

Single "trial" session with chromated glycerin permits to select patients at risk of developing postsclerotherapy hyperpigmentation, and treat these with a milder sclerosant. This approach also reduced the incidence of early postsclerotherapy hyperpigmentation compared with similar series treated with polidocanol alone.

Statistics

Seen <100 times